Edwards Lifesciences (EW) Deferred Taxes (2009 - 2026)

Edwards Lifesciences' Deferred Taxes history runs 18 years deep, the most recent figure standing at -$9.4 million for Q1 2026.

• In Q1 2026, Deferred Taxes fell 138.68% year-over-year to -$9.4 million; the TTM figure through Mar 2026 stood at $83.9 million (down 73.1% YoY), while the FY2025 annual figure was $117.6 million, down 63.64% from the prior year.
• Deferred Taxes was -$9.4 million for Q1 2026 at Edwards Lifesciences, down from $54.4 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $123.0 million in Q3 2024 to a low of -$9.4 million in Q1 2026.
• Historically, Deferred Taxes has averaged $56.4 million across 5 years, with a median of $51.8 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Deferred Taxes soared 1287.18% in 2022, then plunged 138.68% in 2026.
• A 5-year view of Deferred Taxes shows it stood at $105.8 million in 2022, then fell by 13.61% to $91.4 million in 2023, then climbed by 7.77% to $98.5 million in 2024, then tumbled by 44.77% to $54.4 million in 2025, then tumbled by 117.28% to -$9.4 million in 2026.
• The last three Deferred Taxes figures came in at -$9.4 million (Q1 2026), $54.4 million (Q4 2025), and $18.0 million (Q3 2025), per Business Quant data.